semaglutide fda ruling faces new lawsuit from compounders over wight loss drugs Prescriber Insights: Navigating FDA Updates

Get regular exercise to promote sweating and support circulation

What are the alternatives to Januvia (sitagliptin) for treating type 2 diabetes?

doi: 10.1042/bst021170s

In the UK, obesity is thought to cost the NHS 6.1bn per year, government estimates show

The Dangers of Sub-Therapeutic Dosing Some people consider making up for expired medication by taking a slightly higher dose, assuming that if the medication is 50% weaker, they should take twice as much

However, despite the progress in the development of GLP-1 analogues, the overall efficacy of GLP-1 analogues for weight loss is still limited by gastrointestinal side effects, in particular nausea at higher doses (45)